2013-2014 Principal Investigator. “Improving Child and Adolescent Health Care;
Operationalizing and Disseminating Health Improvement for
Medicaid-Eligible Children.” Grant number:
2012-2013 Principal investigator. “Improving Adolescent Health Care.”Funding
Source Vermont Children’s Health Improvement Program.
2011-2012 Principal investigator.; “Family Medicine residency training in high
quality accessible rural primary health care.” Funding source U.S.
Health Resources and Services Administration, Bureau of Health Professions,
Title VII, Section 747, Training for Primary Care Medicine and Dentistry.
Grant number: D58HP08299. Amount $440,471 over three years. University of Vermont.
2007-2010 Principal investigator. “Cultural Competency in Underserved Population Health
Care – A Rural Training Model for Family Practice Residents.” U.S. Health
Resources and Services Administration, Bureau of Health Professions, Title VII,
Section 747 Training for Primary Care Medicine and Dentistry.
Grant number: D58HP00137. Amount: $493,206 over 3 years. University of Vermont.
2004-2007 Local Principal Investigator. "A Randomized, Double-Blind, Active Comparator-
Controlled, Parallel-Group, Study to Evaluate the Safety of Etoricoxib in Patients
With Osteoarthritis or Rheumatoid Arthritis," Sponsor: Merck & Co. Inc,
Whitehouse Station, NJ.
2003 Local Sub-investigator. "A Randomized, Comparator Controlled, Double-Blind
Study of the Liver Safety of Pioglitazone HCL Versus Glyburide With Metformin
and Insulin as Part of Step Therapy in Subjects With Type 2 (Non-Insulin Dependent)
Diabetes. Sponsor: Takeda Pharmaceuticals America, Inc. Lincolnshire, IL.
2001-2003 Local Sub-investigator. "A Randomized, Double-Blind, Double Dummy, Parallel- Group,
Comparative Clinical Trial Evaluation of Fluticasone Propionate/Salmeterol Xinafoate
(250/50mcg BID via Diskus) to Ipratropium Bromide/Albuterol Sulfate (36mcg/206mcg QID)
Inhalation Aerosol in Subjects with Chronic Obstructive Pulmonary Disease (COPD).
Sponsor: GlaxoSmithKline, Research Triangle Park, NC.
2001-2002 Local Principal Investigator. "A Randomized, Double-Blind, Placebo-Controlled,
Forced Titration Study of Ascending Doses of CS-866, Losartan and Valsartan in
Patients with Essential Hypertension." Sponsor: Sarikyo, New York, NY.
2012 King, JG, B Flynn, L Vance. "Shared decision making in the prediabetes visit”;STFM Resource library, www.afmdrl.org
2012 King, JG.; “How accurate are the commonly available tests for H. pylori Infection?”
Desk Answer for the Family Physicians Inquires Network,
Accepted for publication. June 2012.
2012 King, JG and P Han. “Formats for understanding probability over time” and Linder S. and King, JG. “effect of narratives to
present benefit and risk information.” Both in International Patient Decision Aids Standards Chapter C update on presenting
Probabilities. In press
2012 to be published at http://ipdas.ohri.ca/
2002 King JG. Thumb Spica Casts: Short Arm, Long Arm, and Glove. In: The Clinics Atlas of Office Procedures - Casting and
Splinting of Soft-Tissue
Injuries and Fractures, W-B.Saunders, Philadelphia, 2002:5(3) September
2001 Wright AM, Rexrode CR. Hoffman RH, Lustig MR, Shehan WT, King JG, Marsland DW. Selected Disorders of the
Respiratory System. In:
Family Medicine Principles and Practice, 4th Edition, Springer-Verlag. New York, 1993: 88, 678-684. Update 2001 for 5th